Realise an overall improvement in your vitality and feelings of well-being, now and in the future with Detoxamin®
The lower and middle hemorrhoidal veins bypass the liver-and do not undergo first pass metabolism. This means that the EDTA in Detoxamin goes directly to the organs of your body without being filtered through the liver first. Because of this, the EDTA contained in Detoxamin is very productive
Detoxamin’s mechanism allows the EDTA to absorb through the colon wall while you sleep. Almost all the blood from the rectum makes its way to the superior hemorrhoidal veins, a tributary of the portal system, so absorption through the rectal wall carries EDTA in Detoxamin to the portal vein. The lower and middle hemorrhoidal veins bypass the liver, and do not undergo first pass metabolism.
Detoxamin also introduces EDTA directly into the systemic circulation, efficiently bypassing the portal circulation and the liver metabolism on the first pass. Rectal absorption may also occur through the lymphatic system and, in some cases, largely through the blood via the vena cava.
The efficacy of Detoxamin’s formula is based on solid scientific framework and verified through clinical trials, and offers many advantages both over the expensive intravenous method of EDTA chelation. Eliminates the the use of needles via the intravenous method, and the risk of other communicable blood-borne diseases.
Detoxamin allows absorption into the Lymphatic System unlike any other chelators known. The most powerful free radical fighter you have is your lymphatic system. Your lymphatic system holds 80% of your body’s anti-oxidant capacity and is your body’s second circulatory system. Wherever your blood stream goes, the lymphatic system is right next to it. In fact, the lymphatic stream parallels the blood stream.
The Calcium EDTA in Detoxamin has an extra chemical bond compared to the older Disodium EDTA. This gives Detoxamin EDTA an affinity for MERCURY. Mercury is also excreted from the body through the feces, because Detoxamin utilizes the colon wall for EDTA assimilation, it is a powerful Mercury chelator, making it possible to eliminate DMPS in some patients.
The rectal mucosa (rectum) is much more capable than the gastric mucosa (stomach) of tolerating various supplement related irritations. This is why patients who can’t tolerate oral methods are given the same supplement in suppository form. In fact, absorption with any oral EDTA tablet is so low that about 150 (500mg) oral EDTA tablets are equal to just 3-5 Detoxamin suppositories.
Detoxamin is a time-release suppository that binds and removes or decreases toxic heavy metal contaminants. Detoxamin uses Calcium Disodium EDTA (CaNa₂), a synthetic amino acid, in a suppository form as a chelating agent in a proprietary natural triglyceride premium USP time-release base.
Four carefully monitored clinical trials revealed no significant adverse effects either reported by patients or within blood chemistry panels of those in the studies. The researchers state that the dosage form is gentle and appears to create little biological burden and is very well tolerated. Several million doses have been administered to hundreds of thousands of patients worldwide.
Toxic Heavy Metal Overload in the adrenal glands reduce the production of hormones, which cause early aging, stress, decreased sex drive and aggravation of menopausal symptoms. Heavy Metal Overload can lead to unresponsiveness of diabetics to their medications. Heavy Metal Overload can lead to neurological diseases such as depression and loss of thinking power. It can also aggravate conditions such as osteoporosis and hypothyroidism. For obvious reasons, removing metals from the body safely has been a concern of physicians for many years. The body has need for approximately 70 friendly trace element heavy metals, but there are another 12 poisonous heavy metals, such as Lead, Mercury, Aluminum, Arsenic, Cadmium, Nickel, etc., that act as poisonous interference to the enzyme systems and metabolism of the body. No matter how many good health supplements or procedures one takes, heavy metal overload will be a detriment to the natural healing functions of the body. . Realise an overall improvement in your vitality and feelings of well-being, now and in the future with Detoxamin®.
[EDTA] doesn’t enter into the cells, rather it circulates outside the cells and cleanses these areas and blood vessels exposed to stress and toxins.
[EDTA] removes heavy metals and toxins from the “wrong places” (blood vessels and joints) and stops free radical damage by scavenging certain minerals that are promoting the free radical process.
Chelation comes from the Greek word “claw,” meaning “to grab,” which is exactly what EDTA does. When a molecule of EDTA travels through the bloodstream and gets near a toxic metal such as lead or mercury, it grabs the destructive particle and binds tightly with it, pulling it out of the membrane or body tissue it was embedded in.
EDTA seizes a positively charged metal ion and surrounds it. This action inactivates the metal, then the body safely eliminates the bound compound, primarily via the kidneys. Imagine pinching a marble between the thumb and forefinger, the marble being the metal ion and the thumb and forefinger being the chelating agent.
Because EDTA has an affinity to heavy particles, it can attract and bind to heavy metals. The toxic ion and the amino acid connect, and because the body regards the EDTA as a foreign substance, it sends it to the kidney for elimination. Both the EDTA and the heavy metals get a free ride into the toilet. Detoxamin, a novel approach.
It’s no mystery to anyone paying attention that we need to remove these toxins to counteract the detrimental effects of toxic pollution. The elimination of toxins can improve your health dramatically. Isn’t it time for you to take a closer look at this remarkable therapy?
by C. Hancke, MD, and K. Flytlie, MD
by Efrain Olszewer, MD, Fuad Calil Sabbag, MD, and James P. Carter, MD, DrPH New Orleans, Louisiana
by H. Richard Casdorph, MD, PhD
by H. Richard Casdorph, MD, PhD and Charles H. Farr, MD, PhD
by EFRAIN OLSZEWER and JAMES P. CARTER
by L. Terry Chappell, MD, and John P. Stahl, PhD
by John A, Friedman, MD, Howard L. Weinberger, MD
by C.J. Rudolph, DO, PhD, E.W. McDonagh, DO, ACGP, and R.K. Barber, BS, ACSM, ETT
by Lewis S. Schanker
by C.J. Rudolph, DO, PhD, E.W. McDonagh, DO, ACGP, and R.K. Barber, BS, ACSM, ETT
by E.W. McDonagh, DO, FACGP, C.J. Rudolph, DO, PhD, E. Cheraskin, MD, DMD
by S.J.S. Flora and S.K. Tandon
by S.J.S. Flora and S.K. Tandon
by H. Joseph Holliday, MD, FACA, RVT
by Wesley J. Adams, PhD, and Charles T. McGee, MD
by Carlos P. Lamar, MD, F.I.C.A.
by Henry A. Schroeder, M.D.
by Elmer M. Cranton, MD, James P. Frackelton
by Rhea V. Morgan, DVM; Laurie K. Pearce, DVM; Frances M. Moore, DVM; Thomas Rossi, DVM, MS
by Ja-Liang Lin, MD
by V. Wunderlich and G. Sydow
by L. Terry Chappell, MD, John P. Stahl, PhD, and Ronald Evans, MA
by C.J. Rudolph, DO, PhD, E.W. McDonagh, DO, ACGP, and Rhonda.K. Barber, BS, ACSM, ETT
by C.J. Rudolph, DO, PhD, E.W. McDonagh, DO, ACGP
by E.W. McDonagh, DO, C.J. Rudolph, DO, E Cheaskin, MD, DMD
by Vicihi Batuman, MD, FACP
by R. Gooneratne and A. Olkowski
by C.J. Rudolph, DO, PhD, FACAM, E.W. McDonagh, DO, ACGP, FACAM
by Hugh D. Riordan, M.D., Emanuel Cheraskin, M.D., D.M.D., and Marvin Dirks, B.D., M.A.
by C.J. Rudolph, DO, PhD, FACAM, R.T. Samuels, OD, and E.W. McDonagh, DO, ACGP, FACAM
by J. Roderick Kitchell, Lawrence E. Meltzer and Marvin J. Seven
by J. H. Olwin and J. L. Koppel
by Bernard L. Oser, Mona Oser and Howard C. Spencer
by Edward W. McDonagh, D.O., Charles J. Rudolph, Ph.D., D.O., and Emanuel Cheaskin, M.D., D.M.D.
by L. Terry Chappell, MD, and John P. Stahl, PhD
by Elmer M. Cranton, MD
by Sidney Jick, M.D. and Robert Karsh, M.D.
by E.W. McDonagh, DO, C.J. Rudolph, DO, PhD, E. Cheraskin, MD, DMD
by EW McDonagh, DO, CJ Rudolph, PhD, DO, E Cheraskin, MD, DMD
by Jin Suk Kim, Donald L. Hamilton, Barry R, Blakley, and Colin G. Rousseaux
by C. B. Burns PhD, B. Currie
by Norman E. Clarke, Sr. M.D., Norman E. Clarke Jr. M.D. and Robert E. Mosher, PhD
by M. Ella, R Behrens, C Northrop, P Wraight and G. Neale Dunn Clinical Nutrition Centre and New Addenbrooke's Hospital, Cambridge, U.K.
1. 1. Press Conference October 17, 2000. Statement by William J. Walsh, Ph.D. Director of Beethoven Research Project. The Health Research Institute and Pfeiffer Treatment Center, Naperville, Illinois.(www.sjsu.edu/depts/beethoven/hair/hairtestpc.html; accessed 6/17/07).
2. 2. “Full of Lead” by Stephen Janis. Baltimore City Paper; 3/9/2005.
3. www.citypaper.com/printStory.asp?id=9738; accessed 6/26/07).
4. “Study Finds Correlation Between Fluorides in Water and Lead Levels.” Press release from Dartmouth News; August 31, 1999. Roger Masters, Nelson A. Rockefeller Professor of Government Emeritus at Dartmouth College. (www.fluoridation.com/lead.htm; accessed 4/23/07).
5. “The Mad Hatter Syndrome: mercury and biological toxicity” by Leigh Erin Connealy, MD. January 06, 2006. (www.newstarget.com/016544.html; accessed 4/23/07).
6. “45 States Have Issued Mercury Advisories: coal-fired power plants.” Source: Environmental Protection Agency and Department of Natural Resources.
7. “Mercury and Fish Advisories lssued for Nine More Waterways. Source: De Ridder Beauregard Daily News. Quoted from The Louisiana Department of Health and Hospitals Environmental Quality.
8. “Dangerous Lead Levels Found in More Homes.” Source: Cincinnati Enquirer. Quoted from the EPA.
9. “Lead Linked to Premature Deaths in Adults: Early Exposure = 46% Higher Mortality.” Source: The Baltimore Sun. Quoted from the CDC. =
10. “California Sues Over Heavy Metal Fish.” Source: Business Report. Quoted from the California Attorney General.
11. “EPA Doubles Estimates of Children with Mercury in Blood.” Source: The News-Press. Quoted from Department of Environmental Protection.
12. “CDC Vaccine Data Leads Scientists to Shocking Discovery: Possible Autism/Neurological Link.” Source: Yahoo News-Quoted from the CDC.
13. “Chromated Copper Arsenate: CCA-Treated Lumber Poses Danger from Arsenic.” Toxico Sci. 2004 Jun;79(2):287-95.
14. “FDA Warns Pregnant Women to Limit Tuna.” Source: Richard Simmons; Los Angeles Times.3/2004.
15. Schober SE, Mirel LB, Graubard BI, Brody DJ, Flegal KM. Blood Lead Levels and Death from All Causes, Cardiovascular Disease, and Cancer: Results from the NHANES III Mortality Study. Environ Health Perspect. 2006 October, 114(10): 1538-1541
16. Doll R, Fishbein L, Infante P, Landrigan P, Lloyd JW, Mason TJ, Mastromatteo E, Norseth T, et al. Problems of epidemiological evidence. Environ. Health Perspect. 1981;40:11- 20.
17. Kazantzis G. Role of cobalt, iron, lead, manganese, mercury, platinum, selenium and titanium in carcinogenesis. Environ/ Health Perspect. 1981;40:143-161.
18. “Smaller power sources on the horizon” by Sandeep Junnakar. Nov. 13, 2002. [http://CNET News.com; 6/26/2007].
19. “Historical Perspectives on the Development of Chelation Therapies.” An Extended Compendium Prepared for the Advanced Training Seminar on Heavy Metal Toxicology. September 1998. Sponsored by the Great Lakes College of Medicine. Prepared by John Parks Trowbridge MD, FACAM, Diplomate ABCT. Permission granted to Life Center Houston to publish on the healthCHOICESnow.com website.
20. “Detoxify or Die.” Sherry A. Rogers, MD. Sand Key Company, lnc. Sarasota, FL. 2002.
21. Multiple Sclerosis Symptoms. (National Multiple Sclerosis Society).
22. Bernard S, Enayati A, Binstock T, Roger H, Redwood L, McGinnis W. Autism: A Unique Type of Mercury Poisoning. ARC Research. April, 2000.
23. Ibid.
24. Dartmouth Toxic Metal Research Program. (A program of the Center for Environmental Health Sciences at Dartmouth). Report: Dartmouth Toxic Metals Research Program: The facts on cadmium.
25. Oral Chelation and Nutritional Replacement Therapy for Chemical & Heavy Metal Toxicity and Cardiovascular Disease by Maile Pouls, Ph.D. (Townsend Letter, 1999).
26. Nickel, nickel carbonyl, and some nickel compounds Health and Safety Guide. World Health Organization, Geneva 1991.
27. Steven Marcus, MD, Professor, Department of Preventive Medicine and Community Health, Associate Professor, Department of Pediatrics, New Jersey Medical School, University of Medicine and Dentistry of New Jersey; Executive and Medical Director, New Jersey Poison Information and Education System; Consulting Staff, Departments of Pediatrics and Internal Medicine, University Hospital, University of Medicine and Dentistry of New Jersey; Consulting Staff, Department of Pediatrics, Newark Beth Israel Medical Centerhttp://www.emedicine.com/emerg/topic42.htm : Toxicity, Arsenic.
28. Clifford Spanierman, MD, Consulting Staff, Departments of Emergency Medicine and Pediatrics, Lutheran General Hospital of Oak Brook, Advocate Health System: http://www.emedicine.com/emerg/topic285.htm ” Toxicity, lron
29. Chen F, Shi X. “lntracellular signal transduction of cells in response to carcinogenic metals.” Crit. Rev. Oncol. Hematol. 2002 Apr;42(1):105- 21.
30. Wang Suwei, Shi Xianglin. “Mechanisms of ‘Cr(Vl)-induced p53 activation: the role of phosphorylation, mdm2 and ERK.” Carcinogenesis. Vol. 22, No. 5. pp. 757-762, 2001. 3. Doll R, Fishbein L, Infante P, Landrigan P, Lloyd JW, Mason TJ, Mastromatteo E, Norseth T et al. Problems of epidemiological evidence. Environ. Health Perspect. 1981;40:11- 20.
31. Kazantzis G. Role of cobalt, iron, lead, manganese, mercury, platinum, selenium and titanium in carcinogenesis. Environ. Health Perspect. 1981;40:143-161.
32. Toxic Heavy Metals: Sources and Specific Effects. (www.extremehealthusa.com).
33. Heavy Metal Toxicity. Life Extension. (www.lef.org/protocols/prtcls- txt/t-prtcl156.htm).
34. Weyermann M, Brenner H. Factors Affecting Bone Demineralization and Blood Lead Levels of Postmenopausal Women-A Population- Based Study from Germany. Environ. Res. 1998; 76 (1):99-25(7).
35. Grizzo LT, Cordellini S. Perinatal Lead Exposure Affects Nitric Oxide and Cycloxygenase Pathways in Aorta. Toxicol. Sci. 2008; 103:207- 214.
36. Siblerud et al. Evidence that mercury from silver dental fillings may be an etiological factor in multiple sclerosis. Science of the Total Environment, 1994 Mar
37. Vimy M. Hahn LJ. Klober R. Takahashi Y. Lorscheider FL. Mercury uptake in sheep fetus from dental fillings, 32nd Annual Meeting of the Canadian Federation of Biological Societies 14-17 June 1989 and 2nd Meeting of the International Society for Trace Element Research in Humans 8/89
38. Clarkson TW, Magos L, Greenwood MR: The transport of elemental mercury into fetal tissues. Biol Neonate 21:239-44, 1972
39. University of Pennsylvania Health System. Death among children and adolescents. (www.pennhealth.com; accessed 6/26/07).
40. Ejaz ul Islam, Xiao-e Yang, Zhen-li He, Qaisar Mahmood. Assessing potential dietary toxicity of heavy metals in selected vegetables and food crops. J Zhejiang Univ. Sci. B. 2007 January; 8(1):1-13.